Medical progress: Implantable left ventricular assist devices

New England Journal of Medicine

Volumn 339, Issue 21, 1998, Pages 1522-1533

  Goldstein, Daniel J ^a   Mehmet, C O Z ^a   Rose, Eric A ^a,b  

^a Howard Hughes Medical Institute   (United States)

^b Milstein Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTIFICIAL HEART; ASSISTED CIRCULATION; BIOMEDICAL ENGINEERING; BIOMEDICAL TECHNOLOGY ASSESSMENT; CONGESTIVE HEART FAILURE; HEART LEFT VENTRICLE; HEART RIGHT VENTRICLE FAILURE; HUMAN; INFECTION; PATIENT SELECTION; PRIORITY JOURNAL; REVIEW; THROMBOEMBOLISM; TREATMENT INDICATION; HEART ASSIST DEVICE; HEART TRANSPLANTATION; HISTORY; PROSTHESIS;

HEART FAILURE, CONGESTIVE; HEART TRANSPLANTATION; HEART-ASSIST DEVICES; HISTORY, 20TH CENTURY; HUMANS; PATIENT SELECTION; PROSTHESIS DESIGN;

EID: 0032547931     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199811193392107     Document Type: Review

References (88)

1. Schocken DD, Arrieta MI, Leaverton PE, Ross EA. Prevalence and mortality rate of congestive heart failure in the United States. J Am Coll Cardiol 1992;20:301-6.
2. Gillum RF. Epidemiology of heart failure in the United States. Am Heart J 1993;126:1042-7.
3. Massie BM, Packer M. Congestive heart failure: current controversies and future prospects. Am J Cardiol 1990;66:429-30.
4. Kannel WB. Epidemiological aspects of heart failure. Cardiol Clin 1989; 7:1-9.
5. Mortality from congestive heart failure - United States, 1980-1990. MMWR Morb Mortal Wkly Rep 1994;43:77-81.
6. Breast cancer incidence and mortality - United States, 1992. MMWR Morb Mortal Wkly Rep 1996;45:833-7.
7. Update: trends in AIDS incidence, deaths, and prevalence - United States, 1996. MMWR Morb Mortal Wkly Rep 1997;46:165-73.
8. Ho KKL, Pinsky JL, Kannel WB, Levy D. The epidemiology of heart failure: the Framingham Study. J Am Coll Cardiol 1993;22:Suppl A:6A-13A.
9. The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 1987;316: 1429-35.
10. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991;325:293-302.
11. Clinical effectiveness and need for long-term circulatory support. In: Institute of Medicine, Committee to Evaluate the Artificial Heart Program of the National Heart, Lung, and Blood Institute. The artificial heart: prototypes, policies, and patients. Washington, D.C.: National Academy Press, 1991:65-84.
12. The First International Congress on Cyclosporine: May 16-19, 1983, Houston, Texas. Transplant Proc 1983;15:Suppl 1-2:2207-3187.
13. Costanzo MR. Selection and treatment of candidates for heart transplantation. Semin Thorac Cardiovasc Surg 1996;8:113-25.
14. Harper AM, Rosendale JD. The UNOS OPTN waiting list and donor registry: 1988-1996. In: Cecka JM, Terasaki PI, eds. Clinical transplants. Los Angeles: UCLA Tissue Typing Laboratory, 1996:69-90.
15. Allen MD, Fishbein DP, McBride M, Ellison M, Daily OP. Who gets a heart? Rationing and rationalizing in heart transplantation. West J Med 1997;166:326-36.
16. McLoughlin MP, Chapman JR, Gordon SV, Ledwich M, Macdonald G, Mohacsi P. "Go on - say yes": a publicity campaign to increase commitment to organ donation on the driver's license in New South Wales. Transplant Proc 1991;23:2693.
17. Evans RW, Manninen DL, Garrison LP Jr, Maier AM. Donor availability as the primary determinant of the future of heart transplantation. JAMA 1986;255:1892-8.
18. Emergy RW, Joyce LD. Directions in cardiac assistance. J Card Surg 1991;6:400-14.
19. Pae WE Jr, Pierce WS. Temporary left ventricular assistance in acute myocardial infarction and cardiogenic shock: rationale and criteria for utilization. Chest 1981;79:692-5.
20. Pennington DG, Samuels LD, Williams G, et al. Experience with the Pierce-Donachy ventricular assist device in postcardiotomy patients in cardiogenic shock. World J Surg 1985;9:37-46.
21. Frazier OH, Rose EA, Macmanus Q, et al. Multicenter clinical evaluation of the HeartMate 1000 IP left ventricular assist device. Ann Thorac Surg 1992;53:1080-90.
22. Pennington DG, McBride LR, Peigh PS, Miller LW, Swartz MT. Eight years' experience with bridging to cardiac transplantation. J Thorac Cardiovasc Surg 1994;107:472-80.
23. Catanese KA, Goldstein DJ, Williams DL, et al. Outpatient left ventricular assist device support: a new destination rather than a bridge. Ann Thorac Surg 1996;62:646-52.
24. Rose EA, Goldstein DJ. Wearable long-term mechanical support for patients with end-stage heart disease: a tenable goal. Ann Thorac Surg 1996;61:399-402.
25. The artificial heart program: current status and history. In: Hogness JR, VanAntwerp M, eds. The artificial heart: prototypes, policies, and patients. Washington, D.C.: National Academy Press, 1991:14-25.
26. DeVries WC, Anderson JL, Joyce LD, et al. Clinical use of the total artificial heart. N Engl J Med 1984;310:273-8.
27. Copeland JG, Levinson MM, Smith RG, et al. The total artificial heart as a bridge to transplantation: a report of two cases. JAMA 1986;256:2991-5.
28. Johnson KE, Prieto M, Joyce LD, Pritzker M, Emery RW. Summary of the clinical use of the Symbion total artificial heart: a registry report. J Heart Lung Transplant 1992;11:103-16.
29. Griffith BP. Interim use of the Jarvik-7 artificial heart: lessons learned at the Presbyterian-University Hospital of Pittsburgh. Ann Thorac Surg 1989;47:158-66.
30. Muneretto C, Solis E, Pavie A, et al. Total artificial heart: survival and complications. Ann Thorac Surg 1989;47:151-7.
31. Portner PM, Oyer PE, Pennington DG, et al. Implantable electrical left ventricular assist system: bridge to transplantation and the future. Ann Thorac Surg 1989;47:142-50.
32. Pennington DG, McBride LR, Kanter KR, et al. Bridging to heart transplantation with circulatory support devices. J Heart Transplant 1989; 8:116-23.
33. Mehta SM, Aufiero TX, Pae WE Jr, Miller CA, Pierce WS. Combined registry for the clinical use of mechanical ventricular assist pumps and the total artificial heart in conjunction with heart transplantation: sixth official report - 1994. J Heart Lung Transplant 1995;14:585-93.
34. Oz MC, Goldstein DJ, Rose EA. Preperitoneal placement of ventricular assist devices: an illustrated stepwise approach. J Card Surg 1995;10: 288-94.
35. McCarthy PM, Sabik JF. Implantable circulatory support devices as a bridge to heart transplantation. Semin Thorac Cardiovasc Surg 1994;6: 174-80.
36. Frazier OH. The development of an implantable, portable, electrically powered left ventricular assist device. Semin Thorac Cardiovasc Surg 1994; 6:181-7.
37. Chen JM, Weinberg AD, Rose EA, et al. Multivariable analysis of factors affecting waiting time to heart transplantation. Ann Thorac Surg 1996;61:570-5.
38. Aria H, Swartz MT, Pennington DG, et al. Importance of ventricular arrhythmias in bridge patients with ventricular assist devices. ASAIO Trans 1991;37:M427-M428.
39. Oz MC, Rose EA, Slater JP, Kuiper JJ, Caranese KA, Levin HR. Malignant ventricular arrhythmias are well tolerated in patients receiving long-term left ventricular assist devices. J Am Coll Cardiol 1994;24:1688-91.
40. Shapiro GC, Leibowitz DW, Oz MC, Weslow RG, Di Tullio MR, Homma S. Diagnosis of patent foramen ovale with transesophageal echocardiography in a patient supported with a left ventricular assist device. J Heart Lung Transplant 1995;14:594-7.
41. Ambrosino N, Opasich C, Crotti P, Cobelli F, Tavazzi L, Rampulla C. Breathing pattern, ventilatory drive and respiratory muscle strength in patients with chronic heart failure. Eur Respir J 1994;7:17-22.
42. Dusman RE, Stanton MS, Miles WM, et al. Clinical features of amiodarone-induced pulmonary toxicity. Circulation 1990;82:51-9.
43. Chau EM, Bailey KR, Mahoney DW, et al. Predictors of reversibility of pulmonary hypertension in cardiac transplant recipients in the first post-operative year. Circulation 1996;94:Suppl II:II-267-II-272.
44. Oz MC, Goldstein DJ, Pepino P, et al. Screening scale predicts patients successfully receiving long-term implantable left ventricular assist devices. Circulation 1995;92:Suppl II:II-169-II-173.
45. Foray A, Williams D, Reemtsma K, Oz MC, Mancini D. Assessment of submaximal exercise capacity in patients with left ventricular assist devices. Circulation 1996;94:Suppl II:II-222-II-226.
46. Nishimura S, Radovancevic, Odegaard P, Myers T, Springer W, Frazier OH. Exercise capacity recovers slowly but fully in patients with a left ventricular assist device. ASAIO J 1996;42:M568-M570.
47. Nakatani S, McCarthy PM, Kottke-Marchant K, et al. Left ventricular echocardiographic and histologic changes: impact of chronic unloading by an implantable ventricular assist device. J Am Coll Cardiol 1996;27:894-901.
48. Scheinin SA, Capek P, Radovencevic B, Duncan JM, McAllister HA, Frazier OH. The effect of prolonged left ventricular support on myocardial histopathology in patients with end-stage cardiomyopathy. ASAIO J 1992; 38:M271-M274.
49. Jacquet L, Zerbe T, Stein KL, Kormos RL, Griffith BP. Evolution of human cardiac myocyte dimension during prolonged mechanical support. J Thorac Cardiovasc Surg 1991;101:256-9.
50. McCarthy PM, Nakatani S, Vargo R, et al. Structural and left ventricular histologic changes after implantable LVAD insertion. Ann Thorac Surg 1995;59:609-13.
51. Levin HR, Oz MC, Chen JM, Packer M, Rose EA, Burkhoff D. Reversal of chronic ventricular dilation in patients with end-stage cardiomyopathy by prolonged mechanical unloading. Circulation 1995;91:2717-20.
52. Lee SH, Osbakken M, Doliba N, Oz M, Mancini D. LVAD therapy improves myocardial mitochondrial metabolism in patients with heart failure. Circulation 1996;94:Suppl I:I-294. abstract.
53. Estrada-Quintero T, Uretsky BF, Murali S, et al. Amelioration of the heart failure state with left ventricular assist system support. J Am Coll Cardiol 1992;19:Suppl A:254A. abstract.
54. James KB, McCarthy PM, Thomas JD, et al. Effect of the implantable left ventricular assist device on neuroendocrine activation in heart failure. Circulation 1995;92:Suppl II:II-191-II-195.
55. Muller J, Wallukat G, Weng Y-G, et al. Weaning from mechanical cardiac support in patients with idiopathic dilated cardiomyopathy. Circulation 1997;96:542-9.
56. Rose EA, Levin HR, Oz MC, et al. Artificial circulatory support with textured interior surfaces: a counterintuitive approach to minimizing thromboembolism. Circulation 1994;90:Suppl II:II-87-II-91.
57. Spanier T, Oz MC, Levin HR, et al. Activation of coagulation and fibrinolytic pathways in patients with left ventricular assist devices. J Thorac Cardiovasc Surg 1996;112:1090-7.
58. Spanier TB, Oz MC, Rose EA, Stern DM, Schmidt AM. Macrophages populating the textured surface left ventricular assist device contribute to systematic autoanticoagulation. J Heart Lung Transpl 1998;17:83. abstract.
59. Morrone TM, Buck LA, Catanese KA, et al. Early progressive mobilization of patients with left ventricular assist devices is safe and optimizes recovery before heart transplantation. J Heart Lung Transplant 1996;15: 423-9.
60. Frazier OH. Chronic left ventricular support with a vented electric assist device. Ann Thorac Surg 1993;55:273-5.
61. Loisance DY, Deleuze PH, Mazzucotelli JP, Le Besnerais P, Dubois-Rande JL. Clinical implantation of the wearable Baxter Novacor ventricular assist system. Ann Thorac Surg 1994;58:551-4.
62. Kormos RL, Borovetz HS, Gasior T, et al. Experience with univentricular support in mortally ill cardiac transplant candidates. Ann Thorac Surg 1990;49:261-71.
63. Goldstein DJ, Seldomridge JA, Chen JM, et al. Use of aprotinin in LVAD recipients reduces blood loss, blood use, and perioperative mortality. Ann Thorac Surg 1995;59:1063-7.
64. DeRose JJ, Argenziano M, Sun BC, Reemtsma K, Oz MC, Rose EA. Implantable left ventricular assist devices: an evolving long-term cardiac replacement therapy. Ann Surg 1997;226:461-8.
65. Salamonsen RF, Kaye D, Esmore DS. Inhalation of nitric oxide provides selective pulmonary vasodilatation, aiding mechanical cardiac assist with the Thoratec left ventricular assist device. Anaesth Intensive Care 1994;22:209-10.
66. Argenziano M, Choudhri AF, Moazami N, et al. Randomized, double-blind trial of inhaled nitric oxide in LVAD recipients with pulmonary hypertension. Ann Thorac Surg 1998;65:340-5.
67. Chen JM, Levin HR, Rose EA, et al. Experience with right ventricular assist devices for perioperative right-sided circulatory failure. Ann Thorac Surg 1996;61:305-10.
68. Shenkar R, Coulson WF, Abraham E. Hemorrhage and resuscitation induce alterations in cytokine expression and the development of acute lung injury. Am J Respir Cell Mol Biol 1994;10:290-7.
69. Horvath CJ, Ferro TJ, Jesmok G, Malik AB. Recombinant tumor necrosis factor increases pulmonary vascular permeability independent of neutrophils. Proc Natl Acad Sci U S A 1988;85:9219-23.
70. Camussi G, Bussolino F, Salvidio G, Baglioni C. Tumor necrosis factor/cachectin stimulates peritoneal macrophages, polymorphonuclear neutrophils, and vascular endothelial cells to synthesize and release platelet-activating factor. J Exp Med 1987;166:1390-404.
71. Horvath CJ, Kaplan JE, Malik AB. Role of platelet-activating factor in mediating tumor necrosis factor alpha-induced pulmonary vasoconstriction and plasma-lymph protein transport. Am Rev Respir Dis 1991;144:1337-41.
72. Ohar JA, Waller KS, Dahms TE. Platelet-activating factor induces selective pulmonary arterial hyperreactivity in isolated perfused rabbit lungs. Am Rev Respir Dis 1993;148:158-63.
73. Bellan JA, Minkes RK, Hood JS, et al. Analysis of pulmonary and systemic vascular responses to platelet-activating factor in the cat. Am J Physiol 1992;263:H234-H243.
74. Slater JP, Rose EA, Levin HR, et al. Low thromboembolic risk without anticoagulation using advanced-design left ventricular assist devices. Ann Thorac Surg 1996;62:1321-7.
75. Moazami N, Roberts K, Argenziano M, et al. Asymptomatic microembolism in patients with long-term ventricular assist support. ASAIO J 1997;43:177-80.
76. Schmid C, Weyand M, Nabavi DG, et al. Cerebral and systemic embolization during left ventricular support with the Novacor N100 device. Ann Thorac Surg 1998;65:1703-10.
77. Goldstein DJ, el-Amir N, Ashton RC Jr, et al. Fungal infections in left ventricular assist device recipients: incidence, prophylaxis, and treatment. ASAIO J 1995;41:873-5.
78. Prendergast TW, Todd BA, Beyer AJ II, et al. Management of left ventricular assist device infection with heart transplantation. Ann Thorac Surg 1997;64:142-7.
79. Fischer SA, Trenholme GM, Costanzo MR, Piccione W. Infectious complications in left ventricular assist device recipients. Clin Infect Dis 1997;24:18-23.
80. Herrmann M, Weyand M, Greshake B, et al. Left ventricular assist device infection is associated with increased mortality but is not a contraindication to transplantation. Circulation 1997;95:814-7.
81. Holman WL, Bourge RC, Spruell RD, Murrah CP, McGiffin DC, Kirklin JK. Ventricular assist devices as a bridge to cardiac transplantation: a prelude to destination therapy. Ann Surg 1997;225:695-704.
82. Nakazawa T, Makinouchi K, Takami Y, Glueck J, Takatani S, Nose Y. The effect of the impeller-driver magnetic coupling distance on hemolysis in a compact centrifugal pump. Artif Organs 1996;20:252-7.
83. el-Amir NG, Gardocki M, Levin HR, et al. Gastrointestinal consequences of left ventricular assist device placement. ASAIO J 1996;42:150-3.
84. Deng MC, Wilhelm M, Weyand M. Long-term left ventricular assist device support: a novel pump rate challenge exercise protocol to monitor native left ventricular function. J Heart Lung Transplant 1997;16:629-35.
85. Levin HR, Oz MC, Catanese KA, Rose EA, Burkhoff D. Transient normalization of systolic and diastolic function after support with a left ventricular assist device in a patient with dilated cardiomyopathy. J Heart Lung Transplant 1996;15:840-2.
86. Mandarino WA, Gorcsan J III, Gasior TA, Pham S, Griffith BP, Kormos RL. Estimation of left ventricular function in patients with a left ventricular assist device. ASAIO J 1995;41:M544-M547.
87. Martin J, Sarai K, Schindler M, van de Loo A, Yoshitake M, Beyersdorf F. MEDOS HIA-VAD biventricular assist device for bridge to recovery in fulminant myocarditis. Ann Thorac Surg 1997;63:1145-6.
88. Copeland JG, Pavie A, Duveau D, et al. Bridge to transplantation with the CardioWest total artificial heart: the international experience 1993 to 1995. J Heart Lung Transplant 1996;15:94-9.